Cargando…
Clinical course and significance of nontuberculous mycobacteria and its subtypes in cystic fibrosis
BACKGROUND: Nontuberculous mycobacteria (NTM) infections in patients with cystic fibrosis (CF) is increasing globally. However, the related epidemiology, comorbidities, and clinical impact of NTM infection remains unclear in the progress of CF lung disease and patient survival. METHODS: We performed...
Autores principales: | Eikani, Maxine S., Nugent, Melodee, Poursina, Arash, Simpson, Pippa, Levy, Hara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035392/ https://www.ncbi.nlm.nih.gov/pubmed/29980189 http://dx.doi.org/10.1186/s12879-018-3200-z |
Ejemplares similares
-
Nontuberculous Mycobacteria in Cystic Fibrosis
por: Skolnik, Kate, et al.
Publicado: (2016) -
Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis
por: Qvist, Tavs, et al.
Publicado: (2014) -
Nontuberculous mycobacteria in gastrostomy fed patients with cystic fibrosis
por: Al-momani, H., et al.
Publicado: (2017) -
Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia
por: Qvist, Tavs, et al.
Publicado: (2015) -
HALTing Nontuberculous Mycobacteria in Cystic Fibrosis Centers: Is There Something in the Water?
por: Olivier, Kenneth N., et al.
Publicado: (2022)